Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 2Active not recruiting 2Not yet recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Oropharyngeal Neoplasms 1Mouth Neoplasms 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1Carcinoma 1

Interventions

Cisplatin 9Radiotherapy 6Carboplatin 6toripalimab 5pembrolizumab 5Surgical Procedures, Operative 5Nivolumab 5Docetaxel 5Cetuximab 5Paclitaxel 4Drug Therapy 4Taxes 3trilaciclib 2tislelizumab 2nimotuzumab 2camrelizumab 2Specimen Handling 2Radiotherapy, Intensity-Modulated 2Magnetic Resonance Spectroscopy 2Injections 2Cyclophosphamide 2Blood Specimen Collection 2130-nm albumin-bound paclitaxel 2spartalizumab 1penpulimab 1fludarabine phosphate 1fludarabine 1dexamethasone-(C21-phosphoramide)-(anti-EGFR) 1dalpiciclib 1anlotinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Squamous Cell Carcinoma of Head and Neck × (225)Ac-DOTA-c(RGDyK) × Clear all
NCT07441681 2026-05-04

Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin

NRG Oncology

Phase 3 Not yet recruiting
454 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡